These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36184568)

  • 1. Effects of the 5'-Triphosphate Metabolites of Ribavirin, Sofosbuvir, Vidarabine, and Molnupiravir on CTP Synthase Catalysis and Filament Formation: Implications for Repurposing Antiviral Agents against SARS-CoV-2.
    Gillis TD; Bearne SL
    ChemMedChem; 2022 Dec; 17(23):e202200399. PubMed ID: 36184568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nudix hydrolase 18 catalyzes the hydrolysis of active triphosphate metabolites of the antivirals remdesivir, ribavirin, and molnupiravir.
    Jemth AS; Scaletti ER; Homan E; Stenmark P; Helleday T; Michel M
    J Biol Chem; 2022 Aug; 298(8):102169. PubMed ID: 35732208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biophysical Analysis of Bacterial CTP Synthase Filaments Formed in the Presence of the Chemotherapeutic Metabolite Gemcitabine-5'-triphosphate.
    McCluskey GD; Bearne SL
    J Mol Biol; 2018 Apr; 430(8):1201-1217. PubMed ID: 29501573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template.
    Gordon CJ; Tchesnokov EP; Schinazi RF; Götte M
    J Biol Chem; 2021 Jul; 297(1):100770. PubMed ID: 33989635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of filament-forming CTP synthases from Arabidopsis thaliana.
    Daumann M; Hickl D; Zimmer D; DeTar RA; Kunz HH; Möhlmann T
    Plant J; 2018 Oct; 96(2):316-328. PubMed ID: 30030857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of conserved glycine residues 142, 143 and 146 reveals Gly(142) is critical for tetramerization of CTP synthase from Escherichia coli.
    Lunn FA; Macleod TJ; Bearne SL
    Biochem J; 2008 May; 412(1):113-21. PubMed ID: 18260824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing Molnupiravir for COVID-19: The Mechanisms of Antiviral Activity.
    Yip AJW; Low ZY; Chow VTK; Lal SK
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Path toward SARS-CoV-2 Attenuation: Metabolic Pressure on CTP Synthesis Rules the Virus Evolution.
    Ou Z; Ouzounis C; Wang D; Sun W; Li J; Chen W; Marlière P; Danchin A
    Genome Biol Evol; 2020 Dec; 12(12):2467-2485. PubMed ID: 33125064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the Potent Inhibition of CTP Synthase by Gemcitabine-5'-Triphosphate.
    McCluskey GD; Mohamady S; Taylor SD; Bearne SL
    Chembiochem; 2016 Dec; 17(23):2240-2249. PubMed ID: 27643605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
    Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
    J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of sofosbuvir/daclatasvir or ribavirin in patients with severe COVID-19.
    Eslami G; Mousaviasl S; Radmanesh E; Jelvay S; Bitaraf S; Simmons B; Wentzel H; Hill A; Sadeghi A; Freeman J; Salmanzadeh S; Esmaeilian H; Mobarak M; Tabibi R; Jafari Kashi AH; Lotfi Z; Talebzadeh SM; Wickramatillake A; Momtazan M; Hajizadeh Farsani M; Marjani S; Mobarak S
    J Antimicrob Chemother; 2020 Nov; 75(11):3366-3372. PubMed ID: 32812051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19.
    Sacramento CQ; Fintelman-Rodrigues N; Temerozo JR; Da Silva APD; Dias SDSG; da Silva CDS; Ferreira AC; Mattos M; Pão CRR; de Freitas CS; Soares VC; Hoelz LVB; Fernandes TVA; Branco FSC; Bastos MM; Boechat N; Saraiva FB; Ferreira MA; Jockusch S; Wang X; Tao C; Chien M; Xie W; Patel D; Garzia A; Tuschl T; Russo JJ; Rajoli RKR; Pedrosa CSG; Vitória G; Souza LRQ; Goto-Silva L; Guimarães MZ; Rehen SK; Owen A; Bozza FA; Bou-Habib DC; Ju J; Bozza PT; Souza TML
    J Antimicrob Chemother; 2021 Jun; 76(7):1874-1885. PubMed ID: 33880524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human genetic risk of treatment with antiviral nucleoside analog drugs that induce lethal mutagenesis: The special case of molnupiravir.
    Waters MD; Warren S; Hughes C; Lewis P; Zhang F
    Environ Mol Mutagen; 2022 Jan; 63(1):37-63. PubMed ID: 35023215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for ligand binding modes of CTP synthase.
    Zhou X; Guo CJ; Chang CC; Zhong J; Hu HH; Lu GM; Liu JL
    Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered cytidine triphosphate synthetase with reduced product inhibition.
    Zhu M; Sun W; Wang Y; Meng J; Zhang D; Guo T; Ouyang P; Ying H; Xie J
    Protein Eng Des Sel; 2014 Jul; 27(7):225-33. PubMed ID: 24902851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of product feedback regulation and drug resistance in cytidine triphosphate synthetases from the structure of a CTP-inhibited complex.
    Endrizzi JA; Kim H; Anderson PM; Baldwin EP
    Biochemistry; 2005 Oct; 44(41):13491-9. PubMed ID: 16216072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GTP-Dependent Regulation of CTP Synthase: Evolving Insights into Allosteric Activation and NH
    Bearne SL; Guo CJ; Liu JL
    Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Systematic Review of the Global Intervention for SARS-CoV-2 Combating: From Drugs Repurposing to Molnupiravir Approval.
    Ashour NA; Abo Elmaaty A; Sarhan AA; Elkaeed EB; Moussa AM; Erfan IA; Al-Karmalawy AA
    Drug Des Devel Ther; 2022; 16():685-715. PubMed ID: 35321497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir.
    Jockusch S; Tao C; Li X; Chien M; Kumar S; Morozova I; Kalachikov S; Russo JJ; Ju J
    Sci Rep; 2020 Oct; 10(1):16577. PubMed ID: 33024223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of lysine residues 297 and 306 in nucleoside triphosphate regulation of E. coli CTP synthase: inactivation by 2',3'-dialdehyde ATP and mutational analyses.
    MacLeod TJ; Lunn FA; Bearne SL
    Biochim Biophys Acta; 2006 Feb; 1764(2):199-210. PubMed ID: 16427816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.